The Design and Synthesis of Potent and Selective Inhibitors of Trypanosoma brucei Glycogen Synthase Kinase 3 for the Treatment of Human African Trypanosomiasis

[Image: see text] Glycogen synthase kinase 3 (GSK3) is a genetically validated drug target for human African trypanosomiasis (HAT), also called African sleeping sickness. We report the synthesis and biological evaluation of aminopyrazole derivatives as Trypanosoma brucei GSK3 short inhibitors. Low n...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Urich, Robert, Grimaldi, Raffaella, Luksch, Torsten, Frearson, Julie A., Brenk, Ruth, Wyatt, Paul G.
Format: Artigo
Jezik:Inglês
Izdano: American Chemical Society 2014
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4175002/
https://ncbi.nlm.nih.gov/pubmed/25198388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm500239b
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki